CHARL.RIV.LAB INTL DL-,01
CHARL.RIV.LAB INTL DL-,01/ US1598641074 /
RV6
|
06/11/2024 21:53:37
|
Diferencia
+26.850
|
Volumen |
Bid21:59:59 |
Ask21:59:59 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
198.000EUR
|
+15.69%
|
77
Volumen de negocios: 14,920.200 |
199.000Volumen de oferta: 69 |
199.950Tamaño/ Volumen/ Formato de Ask: 69 |
10.3 mil millonesEUR |
- |
- |
Descripción de negocio
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
Consejo de gestión & Consejo de supervisión
| CEO |
| James C. Foster |
| Consejo de gestión |
| Flavia Pease, William D. Barbo, Victoria L. Creamer, Birgit Girshick, Joseph W. LaPlume, Shannon M. Parisotto, Brian Bathgate, Ph.D., Matthew L. Daniel, Kerstin Dolph, Colin S. Dunn, Ph.D., Kristen M. Eisenhauer, Professor Julie Frearson, Ph.D., Wilbert Frieling, D.V.M., E.R.T., John C. Ho, M.D., Foster T. Jordan, Michael G. Knell, Mark Mintz, Gina M. Mullane, Barbara J. Patterson |
| Consejo de supervisión |
| James C. Foster, Nancy C. Andrews M.D., Ph.D., Robert J. Bertolini, Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P., George Llado, Martin Mackay, Ph.D., George E. Massaro, C. Richard Reese, Craig B. Thompson, M.D., Richard F. Wallman, Virginia M. (Gina) Wilson |
Datos de la empresa
| Nombre: |
Charles River Laboratories International, Inc. |
| Dirección: |
251 Ballardvale Street,Wilmington, Massachusetts 01887, USA |
| Teléfono: |
+1-781-222-6000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.criver.com |
| Industria: |
Biotechnology |
| Sector: |
Biotechnology |
| Subsector: |
Biotechnology |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
88.30% |
| Fecha de OPI: |
23/06/2000 |
